Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, and Chronic Lymphocytic Leukemia Research.
Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approach.
Auer rod-positive acute leukemia with predominantly lymphoid immunophenotype: Report on 11 cases and review of literature.
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report
A novel class of ZNF384 aberrations in acute leukemia.
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment
CD371 cell surface expression: a unique feature of <i>DUX4</i>-rearranged acute lymphoblastic leukemia
The genetic basis and cell of origin of mixed phenotype acute leukaemia
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
<scp>AIEOP</scp>‐<scp>BFM</scp>Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia
<i>ETV6/RUNX1</i>‐like acute lymphoblastic leukemia: A novel B‐cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia
Quality assessment program for<scp>E</scp>uro<scp>F</scp>low protocols: Summary results of four‐year (2010–2013) quality assurance rounds
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols